UBS-AM invests £66m in new life sciences facility for cancer therapies


UBS Asset Management Real Estate & Private Markets has provided £66m in forward funding for a pharmaceutical facility in Stevenage, pre-let to Autolus Therapeutics on a 20-year lease.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *